Exclusive: U.S. Cardinal Health puts $1.5 billion China business on block – sources

HONG KONG (Reuters) – U.S. drug distributor Cardinal Health has put its China business up for sale, drawing keen interest from state-backed Chinese pharmaceutical firms in a deal that may be worth up to $1.5 billion, sources familiar with the matter said.
( read original story …)


Related Post

Hong Kong actor Eric Tsang denies sexual misconduc...
views 24
HONG KONG — Well-known Hong Kong actor Eric Tsang ...
Young Hong Kong activist Wong gets second prison t...
views 25
HONG KONG — A Hong Kong court sentenced democracy ...
Belachew and Tollesa aim to retain titles in Hong ...
views 31
He will be joined by fellow Kenyans Robert Kwambai...
Hong Kong star Eric Tsang denies sexual assault al...
views 27
Tsang, a household name in Hong Kong, China, Taiwa...
Senior Hong Kong cop’s appeal bid focuses on alter...
views 28
A barrister defending a senior Hong Kong policeman...
Man dies after mainland Chinese fishing boat crash...
views 22
A man died on Saturday after falling into the sea ...
Hong Kong economy could become a victim of growing...
views 14
Already grappling with a slowing economy, Hong Kon...
Arrest of ex-CIA agent fuels Hong Kong’s reputatio...
views 24
However, there are some places where it is more po...
Hong Kong Hang Seng closes at record high
views 28
The Hang Seng index climbed 79 points ... The rece...
From mortgages to NAFTA, the Bank of Canada shows ...
views 33
he was principal business reporter for Radio Telev...